Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

NCT00749775 · clinicaltrials.gov ↗

COMPLETED

Status

3338

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Selara

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.